| 3.7 |
14.8 |
GO:0032690 |
negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 2.2 |
13.4 |
GO:0061143 |
alveolar primary septum development(GO:0061143) |
| 1.7 |
8.4 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 1.4 |
6.8 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 1.3 |
5.3 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 1.3 |
23.4 |
GO:1901750 |
leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 1.3 |
8.8 |
GO:0010133 |
proline catabolic process to glutamate(GO:0010133) |
| 1.2 |
3.7 |
GO:0045362 |
regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 1.2 |
6.2 |
GO:1904245 |
regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
| 1.1 |
4.6 |
GO:0035482 |
gastric motility(GO:0035482) gastric emptying(GO:0035483) |
| 1.0 |
4.1 |
GO:1904106 |
protein localization to microvillus(GO:1904106) |
| 1.0 |
2.9 |
GO:2001190 |
positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
| 0.9 |
5.5 |
GO:0070945 |
neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 0.9 |
3.6 |
GO:0002268 |
follicular dendritic cell differentiation(GO:0002268) |
| 0.9 |
2.6 |
GO:0014876 |
response to injury involved in regulation of muscle adaptation(GO:0014876) |
| 0.8 |
0.8 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.8 |
2.4 |
GO:0010621 |
negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.8 |
1.6 |
GO:1902563 |
regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
| 0.8 |
1.6 |
GO:0080154 |
regulation of fertilization(GO:0080154) |
| 0.8 |
5.5 |
GO:0036101 |
leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.8 |
3.9 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.8 |
3.1 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.8 |
2.3 |
GO:0071629 |
cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.7 |
2.2 |
GO:0015680 |
intracellular copper ion transport(GO:0015680) |
| 0.7 |
2.2 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 0.7 |
8.2 |
GO:1902949 |
positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.7 |
2.9 |
GO:0009822 |
alkaloid catabolic process(GO:0009822) |
| 0.7 |
2.1 |
GO:2000502 |
negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 0.7 |
6.8 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.6 |
0.6 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.6 |
2.5 |
GO:0090119 |
vesicle-mediated cholesterol transport(GO:0090119) |
| 0.6 |
5.6 |
GO:0046618 |
drug export(GO:0046618) |
| 0.6 |
3.1 |
GO:0090076 |
relaxation of skeletal muscle(GO:0090076) |
| 0.6 |
1.2 |
GO:0050766 |
positive regulation of phagocytosis(GO:0050766) |
| 0.6 |
3.1 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 0.6 |
1.8 |
GO:0090427 |
activation of meiosis(GO:0090427) |
| 0.6 |
4.6 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.6 |
1.1 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.6 |
1.7 |
GO:0002838 |
negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
| 0.6 |
1.7 |
GO:0002894 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.6 |
1.7 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.6 |
4.5 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.6 |
4.5 |
GO:0071395 |
response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.5 |
4.9 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.5 |
2.2 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.5 |
0.5 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.5 |
1.6 |
GO:0002731 |
negative regulation of dendritic cell cytokine production(GO:0002731) |
| 0.5 |
3.1 |
GO:1903949 |
positive regulation of atrial cardiac muscle cell action potential(GO:1903949) |
| 0.5 |
1.6 |
GO:0006258 |
UDP-glucose catabolic process(GO:0006258) |
| 0.5 |
10.4 |
GO:1990573 |
potassium ion import across plasma membrane(GO:1990573) |
| 0.5 |
1.5 |
GO:0009080 |
alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.5 |
3.1 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.5 |
6.7 |
GO:0019375 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.5 |
0.5 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.5 |
3.5 |
GO:1903659 |
regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.5 |
3.0 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.5 |
3.0 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.5 |
0.5 |
GO:0051646 |
mitochondrion localization(GO:0051646) |
| 0.5 |
1.9 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 0.5 |
0.5 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.5 |
1.4 |
GO:0021569 |
rhombomere 3 development(GO:0021569) |
| 0.5 |
1.4 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.5 |
10.0 |
GO:0034356 |
NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.5 |
4.3 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.5 |
2.8 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
| 0.5 |
0.5 |
GO:0015993 |
molecular hydrogen transport(GO:0015993) |
| 0.5 |
1.8 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.5 |
0.5 |
GO:0060300 |
regulation of cytokine activity(GO:0060300) |
| 0.5 |
0.5 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.5 |
9.5 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.4 |
1.8 |
GO:0030885 |
regulation of myeloid dendritic cell activation(GO:0030885) |
| 0.4 |
3.1 |
GO:0060332 |
positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.4 |
1.3 |
GO:2000395 |
regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.4 |
1.3 |
GO:0038178 |
complement component C5a signaling pathway(GO:0038178) |
| 0.4 |
1.7 |
GO:0033091 |
positive regulation of immature T cell proliferation(GO:0033091) |
| 0.4 |
5.6 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.4 |
1.2 |
GO:0050760 |
negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.4 |
0.4 |
GO:0009447 |
putrescine catabolic process(GO:0009447) polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.4 |
0.8 |
GO:0019520 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.4 |
2.0 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.4 |
1.6 |
GO:0070845 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.4 |
1.2 |
GO:0031296 |
B cell costimulation(GO:0031296) |
| 0.4 |
2.0 |
GO:0097460 |
ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.4 |
1.6 |
GO:0034445 |
regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.4 |
0.8 |
GO:1901890 |
positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) positive regulation of adherens junction organization(GO:1903393) |
| 0.4 |
1.9 |
GO:0051970 |
negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.4 |
0.4 |
GO:0048146 |
positive regulation of fibroblast proliferation(GO:0048146) |
| 0.4 |
1.1 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.4 |
1.9 |
GO:2000359 |
regulation of binding of sperm to zona pellucida(GO:2000359) |
| 0.4 |
1.1 |
GO:0002416 |
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.4 |
12.0 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.4 |
3.4 |
GO:0097646 |
calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.4 |
1.5 |
GO:0030185 |
nitric oxide transport(GO:0030185) |
| 0.4 |
1.8 |
GO:0071409 |
cellular response to cycloheximide(GO:0071409) |
| 0.4 |
2.2 |
GO:0032768 |
regulation of monooxygenase activity(GO:0032768) |
| 0.4 |
1.8 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.4 |
1.1 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.4 |
1.1 |
GO:1903461 |
Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.4 |
2.5 |
GO:2000501 |
regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.4 |
1.8 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.4 |
1.8 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.4 |
1.1 |
GO:0043105 |
regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.4 |
1.4 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.4 |
1.1 |
GO:0060734 |
regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 0.3 |
0.3 |
GO:0051436 |
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
| 0.3 |
1.0 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.3 |
1.7 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.3 |
2.1 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 0.3 |
0.3 |
GO:0002589 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.3 |
2.0 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.3 |
1.4 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.3 |
2.4 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.3 |
3.3 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.3 |
1.6 |
GO:0090341 |
negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.3 |
1.0 |
GO:0038162 |
erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.3 |
0.3 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.3 |
2.9 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 0.3 |
4.2 |
GO:0051897 |
positive regulation of protein kinase B signaling(GO:0051897) |
| 0.3 |
1.0 |
GO:0014707 |
branchiomeric skeletal muscle development(GO:0014707) |
| 0.3 |
1.3 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.3 |
2.2 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.3 |
0.3 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.3 |
0.9 |
GO:0061580 |
colon epithelial cell migration(GO:0061580) |
| 0.3 |
6.2 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.3 |
1.2 |
GO:0035054 |
embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.3 |
0.9 |
GO:1905069 |
allantois development(GO:1905069) |
| 0.3 |
0.6 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.3 |
1.5 |
GO:1903412 |
response to bile acid(GO:1903412) |
| 0.3 |
1.5 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.3 |
1.8 |
GO:0051673 |
membrane disruption in other organism(GO:0051673) |
| 0.3 |
1.5 |
GO:0006050 |
mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.3 |
0.3 |
GO:0072194 |
kidney smooth muscle tissue development(GO:0072194) |
| 0.3 |
1.2 |
GO:0035791 |
platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.3 |
1.5 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 0.3 |
0.9 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.3 |
0.3 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
| 0.3 |
0.3 |
GO:0035148 |
tube formation(GO:0035148) |
| 0.3 |
0.6 |
GO:0002232 |
leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
| 0.3 |
1.2 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.3 |
0.9 |
GO:0090346 |
nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.3 |
1.7 |
GO:0033277 |
abortive mitotic cell cycle(GO:0033277) |
| 0.3 |
2.5 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.3 |
2.3 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.3 |
1.4 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.3 |
1.1 |
GO:1905224 |
clathrin-coated pit assembly(GO:1905224) |
| 0.3 |
1.1 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.3 |
1.4 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.3 |
4.4 |
GO:0033015 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.3 |
0.8 |
GO:0009443 |
pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.3 |
1.3 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.3 |
2.4 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.3 |
1.3 |
GO:0032571 |
response to vitamin K(GO:0032571) |
| 0.3 |
0.8 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.3 |
1.1 |
GO:0019442 |
tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.3 |
1.3 |
GO:0032425 |
positive regulation of mismatch repair(GO:0032425) |
| 0.3 |
1.3 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.3 |
0.8 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.3 |
0.8 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.3 |
0.8 |
GO:0080120 |
CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.3 |
0.5 |
GO:0035407 |
histone H3-T11 phosphorylation(GO:0035407) |
| 0.3 |
2.3 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.3 |
0.8 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.3 |
0.3 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.3 |
3.1 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.3 |
1.0 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.3 |
0.8 |
GO:0003285 |
septum secundum development(GO:0003285) |
| 0.3 |
0.8 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.3 |
0.8 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.2 |
2.0 |
GO:0070649 |
polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 0.2 |
3.0 |
GO:0043152 |
induction of bacterial agglutination(GO:0043152) |
| 0.2 |
0.7 |
GO:0040040 |
thermosensory behavior(GO:0040040) |
| 0.2 |
1.5 |
GO:1903524 |
positive regulation of blood circulation(GO:1903524) |
| 0.2 |
2.5 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.2 |
1.5 |
GO:0036363 |
transforming growth factor beta activation(GO:0036363) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.2 |
1.2 |
GO:0098502 |
DNA dephosphorylation(GO:0098502) |
| 0.2 |
0.2 |
GO:0016487 |
sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
| 0.2 |
0.7 |
GO:0070904 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.2 |
1.2 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.2 |
2.2 |
GO:0071276 |
cellular response to cadmium ion(GO:0071276) |
| 0.2 |
1.2 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.2 |
0.7 |
GO:2000563 |
positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.2 |
0.2 |
GO:0042116 |
macrophage activation(GO:0042116) |
| 0.2 |
3.1 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.2 |
3.0 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.2 |
1.4 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.2 |
0.7 |
GO:0032827 |
negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
| 0.2 |
0.5 |
GO:0035723 |
interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
| 0.2 |
7.4 |
GO:0072378 |
blood coagulation, fibrin clot formation(GO:0072378) |
| 0.2 |
0.2 |
GO:1990592 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.2 |
1.8 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.2 |
0.7 |
GO:0046041 |
ITP metabolic process(GO:0046041) |
| 0.2 |
0.7 |
GO:0042361 |
menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 0.2 |
0.5 |
GO:0021940 |
positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 0.2 |
3.4 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
| 0.2 |
0.9 |
GO:0060018 |
astrocyte fate commitment(GO:0060018) |
| 0.2 |
1.8 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.2 |
0.7 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 0.2 |
0.7 |
GO:0042133 |
neurotransmitter metabolic process(GO:0042133) |
| 0.2 |
0.2 |
GO:1900738 |
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.2 |
1.3 |
GO:0061074 |
regulation of neural retina development(GO:0061074) |
| 0.2 |
1.3 |
GO:2000611 |
positive regulation of thyroid hormone generation(GO:2000611) |
| 0.2 |
2.2 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.2 |
1.3 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.2 |
0.9 |
GO:0072287 |
metanephric distal tubule morphogenesis(GO:0072287) |
| 0.2 |
1.3 |
GO:0010751 |
negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.2 |
2.2 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.2 |
1.3 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.2 |
0.9 |
GO:1903803 |
glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.2 |
0.4 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.2 |
1.1 |
GO:0055064 |
chloride ion homeostasis(GO:0055064) |
| 0.2 |
1.5 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.2 |
1.1 |
GO:0090156 |
cellular sphingolipid homeostasis(GO:0090156) |
| 0.2 |
0.8 |
GO:0035803 |
egg coat formation(GO:0035803) |
| 0.2 |
0.4 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.2 |
1.3 |
GO:0045072 |
regulation of interferon-gamma biosynthetic process(GO:0045072) |
| 0.2 |
0.6 |
GO:1903526 |
negative regulation of membrane tubulation(GO:1903526) |
| 0.2 |
1.0 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.2 |
0.8 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.2 |
0.4 |
GO:0051873 |
disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
| 0.2 |
0.4 |
GO:0075528 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.2 |
0.4 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.2 |
1.7 |
GO:0045007 |
depurination(GO:0045007) |
| 0.2 |
1.9 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.2 |
2.1 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.2 |
0.4 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.2 |
7.3 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.2 |
1.8 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.2 |
0.8 |
GO:0072313 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.2 |
0.4 |
GO:0038108 |
negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.2 |
0.6 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 0.2 |
0.2 |
GO:2000584 |
regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 0.2 |
2.6 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.2 |
1.2 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.2 |
0.2 |
GO:0015846 |
polyamine transport(GO:0015846) |
| 0.2 |
1.6 |
GO:0000066 |
mitochondrial ornithine transport(GO:0000066) |
| 0.2 |
4.9 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.2 |
0.2 |
GO:0048670 |
regulation of collateral sprouting(GO:0048670) |
| 0.2 |
1.2 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.2 |
1.3 |
GO:0061622 |
glycolytic process through glucose-1-phosphate(GO:0061622) |
| 0.2 |
1.1 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.2 |
0.6 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.2 |
0.9 |
GO:0071934 |
thiamine transmembrane transport(GO:0071934) |
| 0.2 |
0.4 |
GO:2000354 |
regulation of ovarian follicle development(GO:2000354) |
| 0.2 |
3.3 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.2 |
1.3 |
GO:0071316 |
cellular response to nicotine(GO:0071316) |
| 0.2 |
0.2 |
GO:0055069 |
zinc ion homeostasis(GO:0055069) |
| 0.2 |
0.4 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.2 |
1.7 |
GO:1902222 |
L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.2 |
3.1 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.2 |
0.9 |
GO:0014050 |
negative regulation of glutamate secretion(GO:0014050) |
| 0.2 |
0.4 |
GO:0051445 |
regulation of meiotic cell cycle(GO:0051445) |
| 0.2 |
1.6 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.2 |
0.4 |
GO:0030593 |
neutrophil chemotaxis(GO:0030593) |
| 0.2 |
0.9 |
GO:1904098 |
regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.2 |
0.2 |
GO:0051919 |
positive regulation of fibrinolysis(GO:0051919) |
| 0.2 |
1.4 |
GO:0038195 |
urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.2 |
4.9 |
GO:0051412 |
response to corticosterone(GO:0051412) |
| 0.2 |
0.5 |
GO:1902463 |
protein localization to cell leading edge(GO:1902463) |
| 0.2 |
2.1 |
GO:0015942 |
formate metabolic process(GO:0015942) |
| 0.2 |
6.4 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.2 |
0.7 |
GO:0086097 |
phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.2 |
0.4 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.2 |
0.9 |
GO:0006203 |
dGTP catabolic process(GO:0006203) |
| 0.2 |
0.5 |
GO:1903984 |
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.2 |
0.5 |
GO:0035623 |
renal glucose absorption(GO:0035623) |
| 0.2 |
1.1 |
GO:0043380 |
regulation of memory T cell differentiation(GO:0043380) |
| 0.2 |
1.7 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.2 |
3.0 |
GO:0046185 |
aldehyde catabolic process(GO:0046185) |
| 0.2 |
0.5 |
GO:0005985 |
sucrose metabolic process(GO:0005985) vacuolar sequestering(GO:0043181) |
| 0.2 |
2.4 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.2 |
0.9 |
GO:0008204 |
ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.2 |
0.2 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.2 |
2.2 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.2 |
2.0 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.2 |
0.5 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.2 |
1.0 |
GO:0035026 |
leading edge cell differentiation(GO:0035026) |
| 0.2 |
2.0 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.2 |
0.8 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
| 0.2 |
0.3 |
GO:1902568 |
regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.2 |
0.8 |
GO:0033383 |
geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) farnesyl diphosphate metabolic process(GO:0045338) |
| 0.2 |
0.3 |
GO:0048022 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.2 |
0.8 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.2 |
0.8 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.2 |
0.3 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.2 |
0.7 |
GO:0060168 |
positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.2 |
0.3 |
GO:0010916 |
regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
| 0.2 |
0.7 |
GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.2 |
0.5 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.2 |
0.8 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.2 |
0.7 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.2 |
2.0 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.2 |
3.9 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.2 |
0.2 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.2 |
1.6 |
GO:0051024 |
positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.2 |
1.9 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.2 |
0.2 |
GO:1990167 |
protein K27-linked deubiquitination(GO:1990167) |
| 0.2 |
1.1 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.2 |
1.1 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.2 |
0.2 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.2 |
0.6 |
GO:0019747 |
regulation of isoprenoid metabolic process(GO:0019747) |
| 0.2 |
1.0 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.2 |
0.5 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 0.2 |
0.8 |
GO:0072709 |
cellular response to sorbitol(GO:0072709) |
| 0.2 |
0.2 |
GO:0014016 |
neuroblast differentiation(GO:0014016) |
| 0.2 |
0.6 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.2 |
0.6 |
GO:0048200 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.2 |
1.3 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.2 |
0.6 |
GO:0071469 |
cellular response to alkaline pH(GO:0071469) |
| 0.2 |
0.2 |
GO:1901993 |
meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) |
| 0.2 |
3.1 |
GO:0090023 |
positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.2 |
0.3 |
GO:0016129 |
phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.2 |
0.8 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.2 |
0.6 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.2 |
0.9 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 0.2 |
0.9 |
GO:0043550 |
regulation of lipid kinase activity(GO:0043550) |
| 0.2 |
0.3 |
GO:0051149 |
positive regulation of muscle cell differentiation(GO:0051149) |
| 0.2 |
1.1 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.2 |
16.7 |
GO:0060337 |
type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.2 |
0.5 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.2 |
1.5 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.2 |
0.5 |
GO:0010159 |
specification of organ position(GO:0010159) |
| 0.1 |
0.6 |
GO:0043308 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
| 0.1 |
1.5 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.1 |
1.2 |
GO:1904469 |
positive regulation of tumor necrosis factor secretion(GO:1904469) |
| 0.1 |
0.6 |
GO:0019740 |
regulation of nitrogen utilization(GO:0006808) nitrogen utilization(GO:0019740) |
| 0.1 |
0.3 |
GO:0010513 |
positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
| 0.1 |
0.3 |
GO:0030186 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.1 |
2.5 |
GO:0045023 |
G0 to G1 transition(GO:0045023) |
| 0.1 |
0.7 |
GO:0044800 |
fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.1 |
3.2 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.1 |
0.1 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.1 |
0.4 |
GO:0045744 |
negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.1 |
0.7 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.1 |
0.4 |
GO:1902283 |
negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.1 |
0.7 |
GO:0048749 |
compound eye development(GO:0048749) |
| 0.1 |
2.2 |
GO:0010988 |
regulation of low-density lipoprotein particle clearance(GO:0010988) |
| 0.1 |
0.9 |
GO:0019413 |
acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
| 0.1 |
0.4 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 |
1.0 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.1 |
2.7 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 |
0.4 |
GO:0002818 |
intracellular defense response(GO:0002818) |
| 0.1 |
0.6 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.1 |
2.1 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 |
1.4 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 |
0.1 |
GO:0035284 |
central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.1 |
1.8 |
GO:0000050 |
urea cycle(GO:0000050) |
| 0.1 |
2.9 |
GO:1990001 |
inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.1 |
1.2 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.1 |
0.5 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.1 |
0.7 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.1 |
0.3 |
GO:0016999 |
antibiotic metabolic process(GO:0016999) |
| 0.1 |
0.5 |
GO:1903862 |
positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.1 |
0.4 |
GO:0032509 |
endosome transport via multivesicular body sorting pathway(GO:0032509) |
| 0.1 |
0.8 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.1 |
0.3 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.1 |
0.4 |
GO:0071449 |
cellular response to lipid hydroperoxide(GO:0071449) |
| 0.1 |
0.1 |
GO:0002767 |
immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 0.1 |
1.7 |
GO:0018231 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
2.0 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.1 |
0.5 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.1 |
0.7 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.1 |
0.3 |
GO:0042348 |
regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
| 0.1 |
0.5 |
GO:1903721 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.1 |
0.3 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 |
0.4 |
GO:1900106 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.1 |
0.4 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.1 |
0.3 |
GO:0042214 |
terpene metabolic process(GO:0042214) |
| 0.1 |
1.6 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 |
0.3 |
GO:0007567 |
parturition(GO:0007567) |
| 0.1 |
0.4 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.1 |
0.5 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.1 |
1.0 |
GO:0045840 |
positive regulation of mitotic nuclear division(GO:0045840) |
| 0.1 |
0.4 |
GO:0097116 |
gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.1 |
0.4 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.1 |
1.1 |
GO:0072656 |
maintenance of protein location in mitochondrion(GO:0072656) |
| 0.1 |
0.3 |
GO:0003011 |
diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
| 0.1 |
0.4 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.1 |
0.6 |
GO:0045591 |
positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.1 |
0.5 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 |
0.3 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.1 |
0.8 |
GO:0052551 |
response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.1 |
1.1 |
GO:1904637 |
response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.1 |
0.4 |
GO:0002023 |
reduction of food intake in response to dietary excess(GO:0002023) |
| 0.1 |
0.6 |
GO:0015860 |
purine nucleoside transmembrane transport(GO:0015860) |
| 0.1 |
0.1 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) regulation of glutamate metabolic process(GO:2000211) |
| 0.1 |
0.7 |
GO:0070221 |
sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.1 |
0.2 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.1 |
0.5 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.1 |
1.0 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.1 |
0.2 |
GO:0019344 |
cysteine biosynthetic process(GO:0019344) |
| 0.1 |
0.6 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.1 |
1.8 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.1 |
2.9 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.1 |
0.2 |
GO:0046532 |
regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.1 |
0.5 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.1 |
1.8 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.1 |
0.4 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.1 |
0.4 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) |
| 0.1 |
0.2 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.1 |
0.1 |
GO:0061371 |
determination of heart left/right asymmetry(GO:0061371) |
| 0.1 |
0.1 |
GO:1904479 |
negative regulation of intestinal absorption(GO:1904479) |
| 0.1 |
0.2 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.1 |
0.4 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 0.1 |
0.5 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.1 |
0.5 |
GO:0034036 |
purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.1 |
0.4 |
GO:0060823 |
canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.1 |
0.9 |
GO:0007368 |
determination of left/right symmetry(GO:0007368) |
| 0.1 |
0.2 |
GO:0021885 |
forebrain cell migration(GO:0021885) |
| 0.1 |
1.4 |
GO:0031018 |
endocrine pancreas development(GO:0031018) |
| 0.1 |
0.2 |
GO:0097106 |
postsynaptic density organization(GO:0097106) |
| 0.1 |
0.6 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.1 |
0.5 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.1 |
0.2 |
GO:0015949 |
nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.1 |
8.9 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 |
0.4 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.1 |
1.6 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
0.1 |
GO:0006533 |
aspartate catabolic process(GO:0006533) |
| 0.1 |
4.9 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.1 |
0.3 |
GO:1904428 |
negative regulation of tubulin deacetylation(GO:1904428) |
| 0.1 |
1.2 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.1 |
0.9 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.1 |
0.5 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.1 |
0.5 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.1 |
0.3 |
GO:0071907 |
determination of digestive tract left/right asymmetry(GO:0071907) |
| 0.1 |
0.5 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.1 |
0.2 |
GO:0060031 |
mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
| 0.1 |
0.2 |
GO:1904415 |
regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.1 |
0.7 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.1 |
7.9 |
GO:0002448 |
mast cell mediated immunity(GO:0002448) |
| 0.1 |
0.2 |
GO:0019364 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.1 |
0.6 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 |
0.5 |
GO:1902990 |
mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.1 |
1.1 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 |
4.4 |
GO:0035082 |
axoneme assembly(GO:0035082) |
| 0.1 |
0.3 |
GO:0060283 |
negative regulation of oocyte development(GO:0060283) |
| 0.1 |
0.6 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.1 |
0.3 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
| 0.1 |
0.4 |
GO:0060454 |
detection of temperature stimulus involved in thermoception(GO:0050960) positive regulation of gastric acid secretion(GO:0060454) response to capsazepine(GO:1901594) |
| 0.1 |
0.7 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
0.4 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 0.1 |
0.2 |
GO:1901656 |
glycoside transport(GO:1901656) |
| 0.1 |
1.1 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.1 |
2.1 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 |
0.4 |
GO:1901382 |
chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.1 |
1.8 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 |
0.7 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.1 |
0.4 |
GO:2000230 |
pancreatic stellate cell proliferation(GO:0072343) response to metformin(GO:1901558) regulation of pancreatic stellate cell proliferation(GO:2000229) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.1 |
0.6 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.1 |
0.3 |
GO:0031548 |
regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.1 |
0.1 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.1 |
0.3 |
GO:0003331 |
regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.1 |
1.6 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.1 |
0.8 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.1 |
0.1 |
GO:0046439 |
cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 0.1 |
1.8 |
GO:1904714 |
regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 |
0.5 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 |
0.6 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.1 |
1.2 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.1 |
0.2 |
GO:1902725 |
negative regulation of satellite cell differentiation(GO:1902725) |
| 0.1 |
3.9 |
GO:0048247 |
lymphocyte chemotaxis(GO:0048247) |
| 0.1 |
0.3 |
GO:0060730 |
regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 0.1 |
0.2 |
GO:0021530 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.1 |
0.5 |
GO:0010269 |
response to selenium ion(GO:0010269) |
| 0.1 |
0.6 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.1 |
0.2 |
GO:0003129 |
heart induction(GO:0003129) |
| 0.1 |
0.2 |
GO:0097187 |
dentinogenesis(GO:0097187) |
| 0.1 |
0.2 |
GO:0002428 |
antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
| 0.1 |
0.5 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 0.1 |
1.7 |
GO:1902884 |
positive regulation of response to oxidative stress(GO:1902884) |
| 0.1 |
0.4 |
GO:0090299 |
regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.1 |
1.8 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 0.1 |
0.5 |
GO:0008582 |
regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.1 |
5.5 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.1 |
0.6 |
GO:0036309 |
protein localization to M-band(GO:0036309) |
| 0.1 |
0.3 |
GO:0043438 |
acetoacetic acid metabolic process(GO:0043438) |
| 0.1 |
1.5 |
GO:0090037 |
positive regulation of protein kinase C signaling(GO:0090037) |
| 0.1 |
0.8 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.1 |
0.2 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.1 |
0.5 |
GO:1903969 |
mammary gland fat development(GO:0060611) regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) regulation of response to macrophage colony-stimulating factor(GO:1903969) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) positive regulation of microglial cell migration(GO:1904141) |
| 0.1 |
0.9 |
GO:0071830 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.1 |
0.6 |
GO:0060480 |
lung goblet cell differentiation(GO:0060480) |
| 0.1 |
0.8 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.1 |
0.6 |
GO:0043128 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.1 |
0.4 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 |
0.2 |
GO:0060287 |
epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.1 |
0.6 |
GO:1902164 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.1 |
0.8 |
GO:0032226 |
positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 0.1 |
0.2 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.1 |
0.6 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 |
0.4 |
GO:0051754 |
meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.1 |
0.6 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.1 |
0.8 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.1 |
0.2 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.1 |
0.7 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 |
0.1 |
GO:0046459 |
short-chain fatty acid metabolic process(GO:0046459) |
| 0.1 |
0.5 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.1 |
0.3 |
GO:0046530 |
photoreceptor cell differentiation(GO:0046530) |
| 0.1 |
0.2 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.1 |
0.7 |
GO:0021675 |
nerve development(GO:0021675) |
| 0.1 |
0.3 |
GO:0006531 |
aspartate metabolic process(GO:0006531) |
| 0.1 |
0.9 |
GO:0003096 |
renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.1 |
1.9 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.1 |
1.2 |
GO:0071554 |
cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
| 0.1 |
0.8 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
| 0.1 |
0.6 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.1 |
0.8 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.1 |
0.1 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.1 |
0.4 |
GO:0006480 |
N-terminal protein amino acid methylation(GO:0006480) |
| 0.1 |
0.3 |
GO:0098884 |
postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 0.1 |
0.8 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.1 |
0.4 |
GO:2001176 |
mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.1 |
0.9 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
1.6 |
GO:0090662 |
ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.1 |
0.3 |
GO:0042737 |
drug catabolic process(GO:0042737) |
| 0.1 |
2.1 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 |
0.3 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.1 |
0.2 |
GO:0001810 |
type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) regulation of type I hypersensitivity(GO:0001810) type II hypersensitivity(GO:0002445) negative regulation of dendritic cell antigen processing and presentation(GO:0002605) regulation of type II hypersensitivity(GO:0002892) type I hypersensitivity(GO:0016068) regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
| 0.1 |
0.4 |
GO:0022405 |
molting cycle process(GO:0022404) hair cycle process(GO:0022405) |
| 0.1 |
1.1 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 |
0.6 |
GO:0036152 |
phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.1 |
2.3 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.1 |
0.4 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.1 |
0.9 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.1 |
0.4 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 |
0.4 |
GO:0050992 |
dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.1 |
0.3 |
GO:0061370 |
testosterone biosynthetic process(GO:0061370) |
| 0.1 |
0.9 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 |
0.9 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.1 |
0.4 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.1 |
0.4 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.1 |
1.4 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.1 |
1.4 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 |
0.1 |
GO:0046833 |
positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
| 0.1 |
0.3 |
GO:0021912 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
| 0.1 |
0.1 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 0.1 |
0.5 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.3 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.1 |
1.0 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.1 |
0.3 |
GO:0034499 |
late endosome to Golgi transport(GO:0034499) |
| 0.1 |
0.3 |
GO:0045209 |
MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.1 |
0.5 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 0.1 |
1.7 |
GO:0030207 |
chondroitin sulfate catabolic process(GO:0030207) |
| 0.1 |
0.3 |
GO:0006570 |
tyrosine metabolic process(GO:0006570) |
| 0.1 |
1.5 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.1 |
0.8 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.1 |
1.9 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 |
0.4 |
GO:0045963 |
cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) positive regulation of homocysteine metabolic process(GO:0050668) |
| 0.1 |
0.3 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.1 |
0.3 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.1 |
0.5 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 |
0.1 |
GO:0002032 |
desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.1 |
1.0 |
GO:0003310 |
pancreatic A cell differentiation(GO:0003310) |
| 0.1 |
0.1 |
GO:0048320 |
axial mesoderm morphogenesis(GO:0048319) axial mesoderm formation(GO:0048320) |
| 0.1 |
0.4 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.1 |
0.2 |
GO:0052422 |
modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.1 |
1.2 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.1 |
0.7 |
GO:0044331 |
cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.1 |
2.1 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.1 |
0.4 |
GO:0051454 |
pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.1 |
0.2 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.1 |
0.8 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.1 |
1.7 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 |
0.2 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.1 |
3.8 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.1 |
0.6 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.1 |
0.8 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.1 |
0.2 |
GO:0060979 |
vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.1 |
1.4 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.1 |
0.5 |
GO:0042262 |
DNA protection(GO:0042262) |
| 0.1 |
1.5 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.1 |
0.4 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.1 |
0.2 |
GO:0006705 |
mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.1 |
0.2 |
GO:1902263 |
apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 0.1 |
0.1 |
GO:1990918 |
double-strand break repair involved in meiotic recombination(GO:1990918) |
| 0.1 |
0.2 |
GO:1904604 |
regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
| 0.1 |
2.5 |
GO:0043030 |
regulation of macrophage activation(GO:0043030) |
| 0.1 |
2.1 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.1 |
0.8 |
GO:0009133 |
nucleoside diphosphate biosynthetic process(GO:0009133) |
| 0.1 |
0.7 |
GO:0046549 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.1 |
0.2 |
GO:0051790 |
short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.1 |
0.2 |
GO:0001694 |
histamine biosynthetic process(GO:0001694) |
| 0.1 |
0.4 |
GO:0001836 |
release of cytochrome c from mitochondria(GO:0001836) |
| 0.1 |
0.1 |
GO:0052205 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.1 |
0.5 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.1 |
0.4 |
GO:0030573 |
bile acid catabolic process(GO:0030573) |
| 0.1 |
0.5 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.1 |
0.3 |
GO:0042369 |
vitamin D catabolic process(GO:0042369) |
| 0.1 |
4.3 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.1 |
1.8 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.1 |
0.2 |
GO:0045553 |
TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.1 |
0.2 |
GO:0002027 |
regulation of heart rate(GO:0002027) |
| 0.1 |
10.8 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
0.7 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.1 |
1.1 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.1 |
0.7 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 0.1 |
0.3 |
GO:0015698 |
inorganic anion transport(GO:0015698) |
| 0.1 |
0.2 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.9 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.1 |
0.5 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 |
2.7 |
GO:0001964 |
startle response(GO:0001964) |
| 0.1 |
0.3 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.1 |
0.3 |
GO:0090362 |
positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.1 |
0.7 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 |
0.1 |
GO:0051987 |
positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.1 |
0.7 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.1 |
0.7 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.1 |
0.8 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.1 |
0.4 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.1 |
0.2 |
GO:0032971 |
regulation of muscle filament sliding(GO:0032971) |
| 0.1 |
0.5 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.1 |
0.1 |
GO:1904849 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.1 |
2.9 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.1 |
0.9 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 |
0.4 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.1 |
0.4 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.1 |
0.7 |
GO:0009048 |
dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 |
0.4 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 |
0.6 |
GO:0015755 |
fructose transport(GO:0015755) |
| 0.1 |
0.3 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.1 |
0.3 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
| 0.1 |
0.3 |
GO:0048842 |
positive regulation of axon extension involved in axon guidance(GO:0048842) |
| 0.1 |
0.9 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
0.3 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.1 |
2.3 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.1 |
0.7 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.1 |
0.6 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.1 |
0.6 |
GO:0046087 |
cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.1 |
0.2 |
GO:1900075 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.1 |
0.2 |
GO:0036058 |
filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.1 |
0.7 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.1 |
0.4 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.1 |
0.4 |
GO:0060750 |
epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
| 0.1 |
3.1 |
GO:0018146 |
keratan sulfate biosynthetic process(GO:0018146) |
| 0.1 |
0.7 |
GO:1900045 |
negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.1 |
0.1 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.1 |
1.2 |
GO:0036148 |
phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.1 |
0.7 |
GO:0017187 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.1 |
0.6 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.1 |
0.3 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) post-embryonic hemopoiesis(GO:0035166) |
| 0.1 |
0.1 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.1 |
0.2 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
0.7 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.1 |
0.2 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.1 |
0.6 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.1 |
2.5 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 |
0.2 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
| 0.1 |
0.2 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 |
0.4 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.1 |
0.2 |
GO:0002426 |
immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.1 |
0.8 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.1 |
0.5 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.1 |
0.3 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.1 |
0.1 |
GO:1902523 |
positive regulation of protein K63-linked ubiquitination(GO:1902523) |
| 0.1 |
1.2 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.1 |
0.6 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 |
0.2 |
GO:0051969 |
regulation of transmission of nerve impulse(GO:0051969) |
| 0.1 |
0.2 |
GO:0052805 |
histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 0.1 |
0.1 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 |
0.1 |
GO:0002879 |
positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
| 0.1 |
0.1 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 0.1 |
0.1 |
GO:0002018 |
renin-angiotensin regulation of aldosterone production(GO:0002018) |
| 0.1 |
0.4 |
GO:0002378 |
immunoglobulin biosynthetic process(GO:0002378) |
| 0.1 |
0.2 |
GO:0002088 |
lens development in camera-type eye(GO:0002088) |
| 0.1 |
0.2 |
GO:0034473 |
U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
| 0.1 |
0.5 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 |
1.1 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.1 |
0.4 |
GO:0015813 |
L-glutamate transport(GO:0015813) |
| 0.1 |
1.1 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.1 |
0.6 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 |
0.2 |
GO:0051353 |
positive regulation of oxidoreductase activity(GO:0051353) |
| 0.1 |
1.6 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.1 |
0.3 |
GO:0060285 |
cilium-dependent cell motility(GO:0060285) |
| 0.1 |
0.7 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.1 |
0.5 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 |
0.1 |
GO:0042904 |
9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.1 |
0.5 |
GO:0032057 |
negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.1 |
0.3 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.1 |
0.2 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 |
0.2 |
GO:0002913 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.1 |
0.3 |
GO:0003085 |
negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.1 |
0.1 |
GO:0042421 |
norepinephrine biosynthetic process(GO:0042421) |
| 0.1 |
0.5 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.1 |
0.4 |
GO:0033127 |
regulation of histone phosphorylation(GO:0033127) |
| 0.1 |
0.2 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.1 |
0.5 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.1 |
1.2 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 |
2.9 |
GO:0035036 |
sperm-egg recognition(GO:0035036) |
| 0.1 |
0.5 |
GO:0006782 |
protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.1 |
0.2 |
GO:1903697 |
negative regulation of microvillus assembly(GO:1903697) |
| 0.1 |
0.4 |
GO:0045047 |
protein targeting to ER(GO:0045047) |
| 0.1 |
2.0 |
GO:0006536 |
glutamate metabolic process(GO:0006536) |
| 0.1 |
0.6 |
GO:0060665 |
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.1 |
0.3 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.1 |
0.9 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.1 |
1.2 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.1 |
0.2 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.1 |
0.8 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.1 |
1.0 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.1 |
1.0 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
0.2 |
GO:1904585 |
response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
| 0.1 |
0.2 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.1 |
1.6 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.1 |
0.2 |
GO:0034976 |
response to endoplasmic reticulum stress(GO:0034976) |
| 0.1 |
0.1 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 0.1 |
0.5 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.1 |
0.6 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 |
0.7 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.1 |
5.8 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.1 |
0.2 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.1 |
0.3 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 |
0.9 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.1 |
0.6 |
GO:0006828 |
manganese ion transport(GO:0006828) |
| 0.1 |
0.4 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.1 |
1.1 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.1 |
0.1 |
GO:0061687 |
detoxification of inorganic compound(GO:0061687) |
| 0.1 |
0.3 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.1 |
0.1 |
GO:0019060 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 |
1.4 |
GO:0050974 |
detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.1 |
0.3 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.1 |
0.5 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.1 |
0.2 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.0 |
0.2 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.0 |
1.1 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.0 |
0.1 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.0 |
0.6 |
GO:0015691 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.0 |
0.1 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.0 |
0.3 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.0 |
1.4 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.0 |
0.3 |
GO:2000400 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.0 |
0.2 |
GO:1902894 |
negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.0 |
0.3 |
GO:0044878 |
mitotic cytokinesis checkpoint(GO:0044878) |
| 0.0 |
0.3 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.0 |
0.2 |
GO:0048867 |
stem cell fate determination(GO:0048867) |
| 0.0 |
0.2 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.0 |
0.5 |
GO:0036149 |
phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.0 |
1.4 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.0 |
0.4 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.0 |
0.7 |
GO:0018107 |
peptidyl-threonine phosphorylation(GO:0018107) |
| 0.0 |
0.4 |
GO:0046710 |
GDP metabolic process(GO:0046710) |
| 0.0 |
0.7 |
GO:1901078 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.0 |
0.4 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) |
| 0.0 |
0.4 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.0 |
0.1 |
GO:1902490 |
regulation of sperm capacitation(GO:1902490) |
| 0.0 |
0.5 |
GO:0006069 |
ethanol oxidation(GO:0006069) |
| 0.0 |
0.4 |
GO:0002385 |
mucosal immune response(GO:0002385) |
| 0.0 |
0.0 |
GO:0071287 |
cellular response to manganese ion(GO:0071287) |
| 0.0 |
0.3 |
GO:1901386 |
negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.0 |
2.7 |
GO:2000257 |
regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
| 0.0 |
0.1 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.0 |
0.9 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 |
0.5 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.0 |
0.3 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.0 |
0.2 |
GO:0061356 |
Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
| 0.0 |
1.4 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 |
0.3 |
GO:0099518 |
vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
| 0.0 |
1.8 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.0 |
0.3 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.0 |
5.1 |
GO:0006805 |
xenobiotic metabolic process(GO:0006805) |
| 0.0 |
0.1 |
GO:1905146 |
lysosomal protein catabolic process(GO:1905146) |
| 0.0 |
0.3 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.0 |
0.5 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 |
0.5 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.0 |
0.5 |
GO:0090190 |
positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.0 |
0.3 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 0.0 |
0.8 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.0 |
0.2 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.0 |
0.4 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.0 |
0.0 |
GO:0006844 |
acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.0 |
0.1 |
GO:0045618 |
positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.0 |
0.2 |
GO:0001714 |
endodermal cell fate specification(GO:0001714) |
| 0.0 |
0.1 |
GO:0072757 |
cellular response to camptothecin(GO:0072757) |
| 0.0 |
3.7 |
GO:0006521 |
regulation of cellular amino acid metabolic process(GO:0006521) |
| 0.0 |
0.2 |
GO:0061051 |
positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.0 |
0.2 |
GO:0021853 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.0 |
0.2 |
GO:2001162 |
regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 0.0 |
0.2 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.0 |
0.1 |
GO:0015870 |
acetylcholine transport(GO:0015870) |
| 0.0 |
0.1 |
GO:0015865 |
purine nucleotide transport(GO:0015865) |
| 0.0 |
0.7 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.0 |
0.2 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.0 |
0.0 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 0.0 |
1.2 |
GO:1904659 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.0 |
0.3 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.0 |
0.5 |
GO:0071415 |
cellular response to purine-containing compound(GO:0071415) |
| 0.0 |
0.1 |
GO:0046968 |
peptide antigen transport(GO:0046968) |
| 0.0 |
0.4 |
GO:0045076 |
regulation of interleukin-2 biosynthetic process(GO:0045076) |
| 0.0 |
0.2 |
GO:0030421 |
defecation(GO:0030421) |
| 0.0 |
1.6 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 |
1.0 |
GO:0051447 |
negative regulation of meiotic cell cycle(GO:0051447) |
| 0.0 |
0.1 |
GO:0036269 |
swimming behavior(GO:0036269) |
| 0.0 |
0.5 |
GO:0001676 |
long-chain fatty acid metabolic process(GO:0001676) |
| 0.0 |
0.3 |
GO:0052695 |
cellular glucuronidation(GO:0052695) |
| 0.0 |
0.3 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.0 |
0.6 |
GO:0097242 |
beta-amyloid clearance(GO:0097242) |
| 0.0 |
0.1 |
GO:0098712 |
L-glutamate import across plasma membrane(GO:0098712) |
| 0.0 |
0.4 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.0 |
0.1 |
GO:0006707 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
1.1 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.0 |
0.1 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.0 |
1.7 |
GO:0006734 |
NADH metabolic process(GO:0006734) |
| 0.0 |
0.5 |
GO:0009435 |
NAD biosynthetic process(GO:0009435) |
| 0.0 |
0.1 |
GO:0097021 |
lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.0 |
0.2 |
GO:0060180 |
female mating behavior(GO:0060180) |
| 0.0 |
0.2 |
GO:0055070 |
copper ion homeostasis(GO:0055070) |
| 0.0 |
0.2 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.0 |
0.0 |
GO:0001755 |
neural crest cell migration(GO:0001755) |
| 0.0 |
0.3 |
GO:1902218 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.0 |
0.3 |
GO:0044849 |
estrous cycle(GO:0044849) |
| 0.0 |
0.1 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.0 |
0.3 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.0 |
0.2 |
GO:0017185 |
peptidyl-lysine hydroxylation(GO:0017185) |
| 0.0 |
0.5 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.0 |
0.3 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.0 |
0.1 |
GO:0060380 |
regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.0 |
0.3 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.0 |
0.3 |
GO:0009410 |
response to xenobiotic stimulus(GO:0009410) |
| 0.0 |
0.3 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 |
0.1 |
GO:0006848 |
pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.0 |
1.1 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.0 |
0.2 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.0 |
0.4 |
GO:0060297 |
regulation of sarcomere organization(GO:0060297) |
| 0.0 |
0.4 |
GO:0045739 |
positive regulation of DNA repair(GO:0045739) |
| 0.0 |
0.1 |
GO:0030920 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.0 |
0.7 |
GO:0006590 |
thyroid hormone generation(GO:0006590) |
| 0.0 |
1.4 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.0 |
0.6 |
GO:1904380 |
endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.0 |
0.3 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.0 |
0.3 |
GO:0033141 |
positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.0 |
1.2 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.0 |
0.2 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.0 |
0.1 |
GO:1904587 |
response to glycoprotein(GO:1904587) |
| 0.0 |
0.1 |
GO:2000698 |
positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
| 0.0 |
0.1 |
GO:0046603 |
negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.0 |
0.1 |
GO:0070426 |
positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 0.0 |
2.7 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 |
0.3 |
GO:0008595 |
tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.0 |
0.1 |
GO:0061107 |
seminal vesicle development(GO:0061107) |
| 0.0 |
0.1 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.0 |
0.2 |
GO:0002053 |
positive regulation of mesenchymal cell proliferation(GO:0002053) |
| 0.0 |
0.8 |
GO:0007271 |
synaptic transmission, cholinergic(GO:0007271) |
| 0.0 |
0.4 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.0 |
0.1 |
GO:0071140 |
resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.0 |
0.1 |
GO:0043092 |
L-amino acid import(GO:0043092) |
| 0.0 |
0.1 |
GO:2000195 |
negative regulation of female gonad development(GO:2000195) |
| 0.0 |
0.7 |
GO:0061577 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.0 |
3.0 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.0 |
0.2 |
GO:0010761 |
fibroblast migration(GO:0010761) |
| 0.0 |
0.1 |
GO:0015881 |
creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.0 |
0.4 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.0 |
0.2 |
GO:0055009 |
atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.0 |
0.3 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 |
0.1 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 0.0 |
0.1 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.0 |
0.2 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.0 |
0.5 |
GO:0046500 |
S-adenosylmethionine metabolic process(GO:0046500) |
| 0.0 |
0.1 |
GO:0010996 |
response to auditory stimulus(GO:0010996) |
| 0.0 |
0.1 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.0 |
0.0 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.0 |
0.3 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.0 |
0.0 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.0 |
0.1 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.0 |
0.1 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.0 |
0.6 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.0 |
0.1 |
GO:0070857 |
regulation of bile acid biosynthetic process(GO:0070857) |
| 0.0 |
0.3 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.7 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.0 |
0.3 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.0 |
0.1 |
GO:0050893 |
sensory processing(GO:0050893) |
| 0.0 |
0.3 |
GO:0046951 |
ketone body biosynthetic process(GO:0046951) |
| 0.0 |
0.1 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.0 |
0.1 |
GO:0043328 |
protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.0 |
0.1 |
GO:0044245 |
polysaccharide digestion(GO:0044245) |
| 0.0 |
2.5 |
GO:0050911 |
detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 |
0.4 |
GO:0006119 |
oxidative phosphorylation(GO:0006119) |
| 0.0 |
0.1 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.0 |
0.0 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
| 0.0 |
0.1 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.0 |
0.4 |
GO:0070972 |
protein localization to endoplasmic reticulum(GO:0070972) |
| 0.0 |
0.1 |
GO:0046219 |
serotonin biosynthetic process(GO:0042427) indole-containing compound biosynthetic process(GO:0042435) indolalkylamine biosynthetic process(GO:0046219) |
| 0.0 |
0.2 |
GO:0015677 |
copper ion import(GO:0015677) |
| 0.0 |
0.2 |
GO:0051560 |
mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.0 |
0.0 |
GO:0006579 |
amino-acid betaine catabolic process(GO:0006579) |
| 0.0 |
0.2 |
GO:0038171 |
cannabinoid signaling pathway(GO:0038171) |
| 0.0 |
0.0 |
GO:0072577 |
endothelial cell apoptotic process(GO:0072577) |
| 0.0 |
0.2 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.0 |
0.1 |
GO:0050807 |
regulation of synapse organization(GO:0050807) |
| 0.0 |
0.1 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.0 |
0.3 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.0 |
0.1 |
GO:0071205 |
protein localization to paranode region of axon(GO:0002175) protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.0 |
0.1 |
GO:1990654 |
sebum secreting cell proliferation(GO:1990654) |
| 0.0 |
0.1 |
GO:0033189 |
response to vitamin A(GO:0033189) |
| 0.0 |
0.2 |
GO:0007140 |
male meiosis(GO:0007140) |
| 0.0 |
0.2 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.0 |
0.5 |
GO:0031163 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.1 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.0 |
0.1 |
GO:0006704 |
glucocorticoid biosynthetic process(GO:0006704) |
| 0.0 |
0.1 |
GO:0060356 |
leucine import(GO:0060356) |
| 0.0 |
0.7 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.0 |
0.3 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.0 |
0.1 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.0 |
0.0 |
GO:0070383 |
DNA cytosine deamination(GO:0070383) |
| 0.0 |
0.1 |
GO:1901073 |
N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.0 |
0.0 |
GO:0051255 |
spindle midzone assembly(GO:0051255) |
| 0.0 |
0.3 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.0 |
0.1 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.0 |
0.1 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.0 |
0.1 |
GO:1901374 |
acetate ester transport(GO:1901374) |
| 0.0 |
0.1 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.0 |
0.1 |
GO:1904808 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.0 |
0.1 |
GO:2000170 |
negative regulation of gap junction assembly(GO:1903597) positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.0 |
0.2 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 0.0 |
0.1 |
GO:0032411 |
positive regulation of transporter activity(GO:0032411) |
| 0.0 |
0.1 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.0 |
0.6 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 |
0.2 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 |
0.2 |
GO:1904220 |
regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.0 |
0.1 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.0 |
0.2 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.0 |
0.1 |
GO:0030241 |
skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.0 |
0.0 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.0 |
0.2 |
GO:0044211 |
CTP salvage(GO:0044211) |
| 0.0 |
0.1 |
GO:0048743 |
positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.0 |
0.1 |
GO:0043435 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.0 |
0.1 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.0 |
0.1 |
GO:0010453 |
regulation of cell fate commitment(GO:0010453) |
| 0.0 |
0.1 |
GO:0002305 |
gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
| 0.0 |
0.3 |
GO:0043562 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 |
0.1 |
GO:0010867 |
positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.0 |
0.1 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 0.0 |
0.1 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.0 |
0.1 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.0 |
0.1 |
GO:0002005 |
angiotensin catabolic process in blood(GO:0002005) |
| 0.0 |
0.1 |
GO:1900063 |
regulation of peroxisome organization(GO:1900063) |
| 0.0 |
0.3 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.0 |
0.2 |
GO:1904031 |
positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.0 |
0.3 |
GO:0045576 |
mast cell activation(GO:0045576) |
| 0.0 |
0.1 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.0 |
0.1 |
GO:0038042 |
dimeric G-protein coupled receptor signaling pathway(GO:0038042) |
| 0.0 |
0.1 |
GO:0099550 |
trans-synaptic signalling, modulating synaptic transmission(GO:0099550) |
| 0.0 |
0.1 |
GO:0071498 |
cellular response to fluid shear stress(GO:0071498) |
| 0.0 |
0.1 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.0 |
0.3 |
GO:0009125 |
nucleoside monophosphate catabolic process(GO:0009125) |
| 0.0 |
0.1 |
GO:0050728 |
negative regulation of inflammatory response(GO:0050728) |
| 0.0 |
0.1 |
GO:0097210 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.0 |
0.1 |
GO:0010002 |
cardioblast differentiation(GO:0010002) |
| 0.0 |
0.1 |
GO:0009620 |
response to fungus(GO:0009620) |
| 0.0 |
0.0 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.0 |
0.1 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.0 |
0.1 |
GO:0090042 |
tubulin deacetylation(GO:0090042) |
| 0.0 |
0.1 |
GO:0071025 |
RNA surveillance(GO:0071025) |
| 0.0 |
0.8 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 |
0.0 |
GO:0050913 |
sensory perception of bitter taste(GO:0050913) |
| 0.0 |
0.2 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.0 |
0.1 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 0.0 |
0.1 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 |
0.1 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.0 |
0.2 |
GO:0060070 |
canonical Wnt signaling pathway(GO:0060070) |
| 0.0 |
0.2 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.0 |
0.1 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 |
0.0 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.0 |
0.3 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 |
0.1 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.0 |
0.1 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.0 |
0.1 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.0 |
0.2 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.0 |
0.2 |
GO:0034033 |
nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.0 |
0.2 |
GO:0099601 |
regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.0 |
0.3 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 |
0.1 |
GO:0021615 |
glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 |
0.2 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.0 |
0.1 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 |
0.0 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.0 |
0.2 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.0 |
0.1 |
GO:0035641 |
locomotory exploration behavior(GO:0035641) |
| 0.0 |
0.0 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.0 |
0.0 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.0 |
0.3 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.0 |
0.1 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.0 |
0.1 |
GO:0006939 |
smooth muscle contraction(GO:0006939) |
| 0.0 |
0.1 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.0 |
0.1 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.0 |
0.0 |
GO:1900368 |
pre-miRNA export from nucleus(GO:0035281) regulation of RNA interference(GO:1900368) |
| 0.0 |
0.2 |
GO:0001702 |
gastrulation with mouth forming second(GO:0001702) |
| 0.0 |
0.4 |
GO:0050709 |
negative regulation of protein secretion(GO:0050709) |
| 0.0 |
0.1 |
GO:1902572 |
negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.0 |
0.0 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.0 |
0.0 |
GO:0032755 |
positive regulation of interleukin-6 production(GO:0032755) |
| 0.0 |
0.0 |
GO:0070296 |
sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 0.0 |
0.1 |
GO:0042428 |
serotonin metabolic process(GO:0042428) |
| 0.0 |
0.0 |
GO:0051926 |
negative regulation of calcium ion transport(GO:0051926) |
| 0.0 |
0.1 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.0 |
0.2 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.0 |
0.1 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.0 |
0.1 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.0 |
0.0 |
GO:1900227 |
positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.0 |
0.1 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.0 |
0.1 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
